A growing network of psychiatry clinics, research sites and therapeutic retreats specialized in psychedelic medicine
What we do
Ketamine-assisted psychotherapy + other innovative therapies
Psychedelic clinical trials and protocol development
Legal, medically supervised psychedelic experiences
Providing access to innovative, evidence based mental healthcare
Patients are referred to trusted partners for treatments not yet available in the US
Only active in jurisdictions with established regulations for the use of psychedelics
Novamind enables safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites.
We provide ketamine-assisted psychotherapy and other novel treatments through our network of Cedar Psychiatry clinics and operate Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.
Through our retreat partners, we offer additional access to psychedelics in jurisdictions with established regulations for the use of these alternative medicines.
March 22, 2021
Novamind to Present at Benzinga Biotech Conference
March 18, 2021
Novamind Partners with Merck for New Treatment-Resistant Depression Trial
March 03, 2021
Novamind Expands Leadership Team, Accelerating M&A
March 01, 2021
Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter
— Stanislav Grof, MD